Highlights Onconetix, Inc.

Equities

ONCO

US09610B1089

End-of-day quote Nasdaq Other stock markets 23:00:00 13/06/2024 BST			5-day change	1st Jan Change
0.1419 ^USD	-1.73%		-5.02%	-28.33%

05-20	Onconetix, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-11	Onconetix, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Onconetix, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-20	CI
Onconetix, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	04-11	CI
Blue Water Biotech, Inc. acquired ProteoMediX AG for $51.9 million.	12-20	CI
Tranche Update on Blue Water Biotech, Inc.'s Equity Buyback Plan announced on November 10, 2022.	11-17	CI
Blue Water Biotech, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-17	CI
Tranche Update on Blue Water Biotech, Inc.'s Equity Buyback Plan announced on November 10, 2022.	20/10/23	CI
Blue Water Biotech, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	20/10/23	CI
Blue Water Biotech, Inc. Enters into an Exclusive Distribution Agreement with Cardinal Health 105, LLC	03/10/23	CI
Blue Water Biotech, Inc. and Copay Consultants Collaborate to Build Copay Assistance Programs for Blue Water's Commercial Products	10/08/23	CI
Blue Water Biotech, Inc. and Knipper Health, Inc. Knipper Health Join Forces to Distribute Samples for ENTADFI and ZONTIVITY to Physicians	31/07/23	CI
Blue Water Biotech, Inc. Teams with UpScriptHealth to Launch Telemedicine Platform for Benign Prostatic Hyperplasia Asset, ENTADFI	25/07/23	CI
Blue Water Biotech Teams with Advantage Point Solutions to Provide Healthcare Payer Coverage Support	11/07/23	CI
Payrolls Data Awaited Amid Muted Exchange-Traded Funds, Equity Futures Premarket Friday	07/07/23	MT
Blue Water Biotech Secures Regulatory License to Operate as Pharmaceutical Wholesaler in Ohio	07/07/23	MT
Blue Water Biotech Secures License from Ohio State Board of Pharmacy to Operate as Pharmaceutical Wholesaler for Its FDA Approved Products	06/07/23	CI
Blue Water Biotech Signs Master Services Agreement with bfw Advertising to Market and Advertise Commercial Product Portfolio	06/07/23	CI
Blue Water Biotech, Inc. Announces Preliminary Preclinical Data Supporting the Use of Its Norovirus Shell and Plusion Virus-Like Particle Platform to Develop Novel Monkeypox Vaccine Candidate	28/06/23	CI
Blue Water Biotech to Build Sales Team with IQVIA to Market Commercial Portfolio	21/06/23	MT
Blue Water Biotech, Inc. Collaborates with IQVIA to Build Medical Sales Representative Team to Market Commercial Product Portfolio	21/06/23	CI
Blue Water Biotech to Acquire Six Drugs Approved for Multiple Indications in the US in Cash, Stock Deal; Shares Rise Pre-Bell	14/06/23	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Onconetix, Inc.

Equities

ONCO

US09610B1089

Highlights

Filters